Form 4: MANGOCEUTICALS Director Receives 100,000 Share Bonus

MANGOCEUTICALS, INC. Director Lorraine Pamela D'Alessio was granted 100,000 shares of common stock as a discretionary bonus for her board services.

Summary

• Lorraine Pamela D'Alessio, a Director of MANGOCEUTICALS, INC. (MGRX), acquired 100,000 shares of common stock.
• The transaction occurred on September 9, 2025.
• The shares were issued as a discretionary bonus in consideration for services rendered as a member of the Board of Directors.
• The issuance was made under the company's Second Amended and Restated 2022 Equity Incentive Plan.
• Following this transaction, Ms. D'Alessio beneficially owns a total of 136,667 shares of common stock.
• The transaction is exempt pursuant to Rule 16b-3.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even as a bonus, generally indicates alignment of interests and confidence in the company's future, which is a positive signal for investors.

Positives

• A Director received a significant equity grant of 100,000 shares, which aligns her interests more closely with those of shareholders.
• The bonus reflects compensation for services rendered as a Board member, indicating active participation and value contribution to the company.
• The issuance under an existing equity incentive plan demonstrates a structured and approved approach to executive and director compensation.

Future Outlook

NA

Industry Context

This filing is specific to an individual insider transaction and does not provide broader industry context or trends.

Related Party Transactions

• The issuance of 100,000 shares as a discretionary bonus to a director constitutes a related party transaction, as it involves compensation to an insider.

Stakeholder Impact

• Shareholders: Increased alignment of the director's interests with shareholders due to higher equity ownership, potentially fostering greater confidence in management's long-term commitment.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Key Dates

Recommendation

The acquisition of 100,000 shares by a director, even as a bonus, signals increased insider alignment and potential confidence in the company's future. This is a positive indicator, but without broader financial context or strategic updates, it primarily reinforces a 'hold' position for existing investors or warrants further due diligence for potential investors.

Keywords

MANGOCEUTICALS, MGRX, Director Compensation, Equity Grant, Insider Ownership, Form 4, Stock Bonus, Lorraine D'Alessio, Equity Incentive Plan